DeepNiche

Weight-loss shots

FDA flags unapproved GLP-1s and compounding limits

Retatrutide and cagrilintide cannot be used in compounding under federal law and have not been found safe and effective for any condition.

source: FDA

Get DeepNiche

The full briefing is in the app.

More Weight-loss shots clippings